Affect Therapeutics has filed a notice of an exempt offering of securities to raise $18,073,362.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Affect Therapeutics is raising $18,073,362.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Kristin Muhlner played a key role…